# Board of Supervisors Minutes: July 26, 2022 - Meeting date: 2022-07-26 - Document type: minutes - Source format: PDF - Extracted pages: 45 - [Canonical HTML transcript](https://sfbos.info/documents/864/2022-07-26-minutes) - [Authoritative City source](https://sfgov.legistar.com/View.ashx?M=M&ID=989893&GUID=F5560C72-A561-484A-9BFD-4943CA63A7CD) > This text was extracted for search and accessibility. The linked City source is the authoritative public record. ## Structured legislative records ### File 220756: Business and Tax Regulations Code - Disclosure of Vacancy Tax Information; Penalties For Failure to Timely File Vacancy Tax Returns - Pages: 7-8 - Sponsors: Peskin; Chan and Mandelman - Vote 1: final-passage, likely final - Action: 220756 [Business and Tax Regulations Code - Disclosure of Vacancy Tax Information; Penalties For Failure to Timely File Vacancy Tax Returns] Sponsors: Peskin; Chan and Mandelman Ordinance amending the Business and Tax Regulations Code to permit the Tax Collector to make public certain information regarding the Vacancy Tax, and to waive the penalty for failure to timely file Vacancy Tax returns for tax years 2022 and 2023. (Rules Committee) Ordinance No. 188-22 FINALLY PASSED The foregoing items were acted upon by the following vote: - Ayes: Chan, Dorsey, Mandelman, Mar, Melgar, Peskin, Preston, Ronen, Safai, Stefani, Walton ### File 220446: Planning, Administrative, Subdivision Codes; Zoning Map - Density Exception in Residential Districts - Pages: 8-9 - Sponsors: Mandelman; Melgar - Vote 1: amendment - Action: units per lot, and up to six dwelling units per lot in Corner Lots, in all RH (Residential, House) zoning districts, subject to certain requirements, including among others the replacement of protected units; amending the Administrative Code to require new dwelling units constructed pursuant to the density limit exception to be subject to the rent increase limitations of the Rent Ordinance; amending the Subdivision Code to authorize a subdivider that is constructing new dwelling units pursuant to the density exception to submit an application for condominium conversion or a condominium map that includes the existing dwelling units and the new dwelling units that constitute the project; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1, and findings of public necessity, convenience, and welfare under Planning Code, Section 302. Privilege of the floor was granted unanimously to Tom Paulino (Mayor’s Office) who responded to questions raised throughout the discussion. MAYORAL VETO NOT OVERTURNED by the following vote: - Ayes: Chan, Mandelman, Mar, Melgar, Peskin, Preston, Ronen - Noes: Dorsey, Safai, Stefani, Walton ### File 220819: Settlement of Lawsuit - Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. - City to Receive $10,000,000 Total; $5,000,000 Immediately, $5,000,000 in 10 Equal Annual Payments - Pages: 9-10 - Sponsors: Walton; Safai - Vote 1: final-passage, likely final - Action: , Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that the Endo defendants created a public nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law. Supervisor Safai requested to be added as a co-sponsor. FINALLY PASSED by the following vote: - Ayes: Chan, Dorsey, Mandelman, Mar, Melgar, Peskin, Preston, Ronen, Stefani, Walton - Absent: Safai - Vote 2: rescission - Action: Supervisor Safai, seconded by Supervisor Stefani, moved to rescind the previous vote: - Ayes: Chan, Dorsey, Mandelman, Mar, Melgar, Preston, Ronen, Safai, Stefani, Walton - Noes: Peskin - Vote 3: final-passage, likely final - Action: Ordinance No. 170-22 FINALLY PASSED by the following vote: - Ayes: Chan, Dorsey, Mandelman, Mar, Melgar, Peskin, Preston, Ronen, Safai, Stefani, Walton ## Extracted text ### [Page 8](https://sfbos.info/documents/864/2022-07-26-minutes#page-8) Board of Supervisors Meeting Minutes 7/26/2022 REGULAR AGENDA UNFINISHED BUSINESS Vetoed by the Mayor 220446 [Planning, Administrative, Subdivision Codes; Zoning Map - Density Exception in Residential Districts] Sponsors: Mandelman; Melgar Ordinance amending the Planning Code to rezone all Residential, One Family (RH-1) zoning districts, except for Residential, One Family, Detached (RH-1(D)) districts, to Residential, Two Family (RH-2) zoning districts; to rezone the RH-1(D) districts to a new class of residential district called Residential, Two Family, Detached (RH-2(D)) districts; and to provide a density limit exception to permit up to four dwelling units per lot, and up to six dwelling units per lot in Corner Lots, in all RH (Residential, House) zoning districts, subject to certain requirements, including among others the replacement of protected units; amending the Administrative Code to require new dwelling units constructed pursuant to the density limit exception to be subject to the rent increase limitations of the Rent Ordinance; amending the Subdivision Code to authorize a subdivider that is constructing new dwelling units pursuant to the density exception to submit an application for condominium conversion or a condominium map that includes the existing dwelling units and the new dwelling units that constitute the project; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1, and findings of public necessity, convenience, and welfare under Planning Code, Section 302. Privilege of the floor was granted unanimously to Tom Paulino (Mayor’s Office) who responded to questions raised throughout the discussion. MAYORAL VETO NOT OVERTURNED by the following vote: Ayes: 7 - Chan, Mandelman, Mar, Melgar, Peskin, Preston, Ronen Noes: 4 - Dorsey, Safai, Stefani, Walton City and County of San Francisco Page 713 Printed at 4:27 pm on 3/7/24 ### [Page 9](https://sfbos.info/documents/864/2022-07-26-minutes#page-9) Board of Supervisors Meeting Minutes 7/26/2022 From the Board Supervisor Safai was noted absent at 3:01 p.m. 220819 [Settlement of Lawsuit - Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. - City to Receive $10,000,000 Total; $5,000,000 Immediately, $5,000,000 in 10 Equal Annual Payments] Sponsors: Walton; Safai Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco against Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. for $10,000,000 ($5,000,000 immediately and $5,000,000 paid in 10 equal annual payments); the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that the Endo defendants created a public nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law. Supervisor Safai requested to be added as a co-sponsor. FINALLY PASSED by the following vote: Ayes: 10 - Chan, Dorsey, Mandelman, Mar, Melgar, Peskin, Preston, Ronen, Stefani, Walton Absent: 1 - Safai Supervisor Safai, seconded by Supervisor Stefani, moved to rescind the previous vote: Ayes: 10 - Chan, Dorsey, Mandelman, Mar, Melgar, Preston, Ronen, Safai, Stefani, Walton Noes: 1 - Peskin Ordinance No. 170-22 FINALLY PASSED by the following vote: Ayes: 11 - Chan, Dorsey, Mandelman, Mar, Melgar, Peskin, Preston, Ronen, Safai, Stefani, Walton City and County of San Francisco Page 714 Printed at 4:27 pm on 3/7/24